If there were ever any doubt that measles is a dangerous disease, a study published in the journal Science yesterday blows that misconception away by finally explaining how large-scale measles […]
It now costs $10,000 or more per person annually to treat someone with diabetes than someone who doesn’t have the chronic disease, according to a new analysis of large insurance […]
We’re still spending vast amounts of time and money trying to counter the ill effects of a discredited, retracted paper from 1998 that claimed to find a link between the […]
Johnson & Johnson announced today the establishment of an independent advisory board to review cases of terminally ill patients who petition Janssen Pharmaceuticals for expanded access to pre-approval experimental drugs, […]
A new study finds that the healthier we eat over the years, the better shape our brains will be in as we age. In the new research from McMaster University, […]
DUBLIN, IRELAND–(Marketwired – May 7, 2015) – Horizon Pharma plc (NASDAQ: HZNP), a specialty biopharmaceutical company focused on improving patients’ lives by identifying, developing, acquiring and commercializing differentiated and accessible […]
Conference Call and Webcast Today, May 7, 2015 at 4:30 p.m. Eastern Time ANN ARBOR, MI–(Marketwired – May 07, 2015) – Esperion Therapeutics, Inc. (NASDAQ: ESPR), an emerging pharmaceutical company […]
SAN DIEGO–(BUSINESS WIRE)–La Jolla Pharmaceutical Company (Nasdaq: LJPC) (the Company or La Jolla), a leader in the development of innovative therapies intended to significantly improve outcomes in patients suffering from […]
SAN DIEGO–(BUSINESS WIRE)–La Jolla Pharmaceutical Company (Nasdaq: LJPC) (the Company or La Jolla), a leader in the development of innovative therapies intended to significantly improve outcomes in patients suffering from […]
SAN FRANCISCO–(BUSINESS WIRE)–The California Supreme Court today resoundingly endorsed consumers’ right to challenge pharmaceutical pay-for-delay settlements under California competition law. Reversing a grant of summary judgment to Bayer and Barr, […]
